TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR

Rosen Law Firm is notifying investors of a potential securities class action lawsuit against aTyr Pharma regarding allegedly false statements about the efficacy of their drug Efzofitimod, with a lead plaintiff deadline of December 8, 2025.

Insights
ATYR   negative

The lawsuit alleges the company disseminated false and misleading statements about their drug's capabilities, potentially causing investor damages